Author

Moon-Hwa Park

Observed names: M. Park, Moon-hwa Park

Institution: Hanmi Pharmaceutical (South Korea)

Observed institution: Hanmi Pharmaceutical (South Korea)

ORCID: 0009-0006-5281-7348

Observed ORCID: 0009-0006-5281-7348

OpenAlex ID: A5113005244

Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder

2025 · Jee Soo Park, Won Sik Jang, et al. · Korean journal of urology · 4

Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study

2023 · Jun Ho Lee, Yeon Won Park, et al. · Prostate International · 3

Effectiveness and Safety of Very-Low-Dose Rosuvastatin–Ezetimibe Therapy in Korean Patients with Dyslipidaemia: A Multicentre Prospective Observational Study

2025 · Ji Woong Roh, Moon-hwa Park, et al. · Clinical Drug Investigation · 1

Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study

2025 · Hyun Lim, Moon-hwa Park · Korean Journal of Gastroenterology · 1

Pos0146 Increased Risks of Aortic Regurgitation and Atrial Fibrillation in Radiographic Axial Spondyloarthritis Patients: a 10 Year Nationwide Cohort Study

2022 · H.K. Min, K.Y. Kang, et al. · Annals of the Rheumatic Diseases · 1

Effectiveness and Safety of Mirabek Sustained-release 50 mg Tablets in Korean Patients with Overactive Bladder: A Multicenter Observational Study at Tertiary General Hospitals

2025 · Jee Soo Park, Jongchan Kim, et al. · European Urology Open Science

Efficacy and Safety of Quadruple-Drug Fixed-Dose Single-Pill Combination Therapy for Hypertension and Dyslipidemia: A Prospective, Multicenter, Observational Study

2025 · Soohyung Park, Eun Jin Park, et al. · Clinical Therapeutics

The author’s reply

2025 · Jee Soo Park, Won Sik Jang, et al. · Korean journal of urology

Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder

2024 · Jee Soo Park, Won Sik Jang, et al. · Korean journal of urology

Time interval of esomeprazole and dual antiplatelet therapy in patients with cardiocerebrovascular diseases

2024 · Hyunsoo Kim, Moon-Hwa Park, et al. · Medicine

Works count: 10

Citation count: 10

H-index: 2

I10-index: